Adaptive Biotechnologies (ADPT) Competitors $7.41 -0.53 (-6.68%) Closing price 04:00 PM EasternExtended Trading$7.76 +0.35 (+4.72%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADPT vs. PTCT, ZLAB, OGN, ACLX, RNA, RARE, RYTM, SWTX, AKRO, and CRNXShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include PTC Therapeutics (PTCT), Zai Lab (ZLAB), Organon & Co. (OGN), Arcellx (ACLX), Avidity Biosciences (RNA), Ultragenyx Pharmaceutical (RARE), Rhythm Pharmaceuticals (RYTM), SpringWorks Therapeutics (SWTX), Akero Therapeutics (AKRO), and Crinetics Pharmaceuticals (CRNX). These companies are all part of the "pharmaceutical products" industry. Adaptive Biotechnologies vs. PTC Therapeutics Zai Lab Organon & Co. Arcellx Avidity Biosciences Ultragenyx Pharmaceutical Rhythm Pharmaceuticals SpringWorks Therapeutics Akero Therapeutics Crinetics Pharmaceuticals PTC Therapeutics (NASDAQ:PTCT) and Adaptive Biotechnologies (NASDAQ:ADPT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Do analysts rate PTCT or ADPT? PTC Therapeutics currently has a consensus price target of $63.77, indicating a potential upside of 36.46%. Adaptive Biotechnologies has a consensus price target of $9.40, indicating a potential upside of 26.86%. Given PTC Therapeutics' higher probable upside, research analysts clearly believe PTC Therapeutics is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PTC Therapeutics 2 Sell rating(s) 4 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.53Adaptive Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of PTCT or ADPT? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 5.5% of PTC Therapeutics shares are held by company insiders. Comparatively, 6.2% of Adaptive Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to PTCT or ADPT? In the previous week, PTC Therapeutics had 10 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 14 mentions for PTC Therapeutics and 4 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.16 beat PTC Therapeutics' score of 0.65 indicating that Adaptive Biotechnologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PTC Therapeutics 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Adaptive Biotechnologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in PTCT or ADPT? PTC Therapeutics received 471 more outperform votes than Adaptive Biotechnologies when rated by MarketBeat users. Likewise, 61.92% of users gave PTC Therapeutics an outperform vote while only 57.99% of users gave Adaptive Biotechnologies an outperform vote. CompanyUnderperformOutperformPTC TherapeuticsOutperform Votes56961.92% Underperform Votes35038.08% Adaptive BiotechnologiesOutperform Votes9857.99% Underperform Votes7142.01% Which has more volatility & risk, PTCT or ADPT? PTC Therapeutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Adaptive Biotechnologies has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Which has higher earnings & valuation, PTCT or ADPT? Adaptive Biotechnologies has lower revenue, but higher earnings than PTC Therapeutics. PTC Therapeutics is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPTC Therapeutics$806.78M4.57-$626.60M-$4.73-9.88Adaptive Biotechnologies$178.96M6.15-$159.49M-$1.09-6.80 Is PTCT or ADPT more profitable? PTC Therapeutics has a net margin of -50.32% compared to Adaptive Biotechnologies' net margin of -89.12%. PTC Therapeutics' return on equity of 0.00% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets PTC Therapeutics-50.32% N/A -16.44% Adaptive Biotechnologies -89.12%-64.65%-26.45% SummaryPTC Therapeutics beats Adaptive Biotechnologies on 10 of the 19 factors compared between the two stocks. Remove Ads Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.10B$2.97B$5.54B$7.49BDividend YieldN/A1.53%4.86%4.04%P/E Ratio-6.8030.4323.2518.07Price / Sales6.15383.26361.2686.83Price / CashN/A168.6838.1634.64Price / Book5.413.646.493.99Net Income-$159.49M-$72.06M$3.21B$247.18M7 Day Performance-9.85%-10.59%-6.42%-6.42%1 Month Performance-8.52%-16.74%-0.68%-7.44%1 Year Performance176.49%-30.77%6.05%-4.31% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies4.0278 of 5 stars$7.41-6.7%$9.40+26.9%+166.4%$1.10B$178.96M-6.80790Positive NewsGap DownPTCTPTC Therapeutics3.8138 of 5 stars$50.96-6.0%$63.77+25.1%+70.3%$4.02B$806.78M-8.581,410Analyst ForecastNews CoverageGap DownHigh Trading VolumeZLABZai Lab2.3209 of 5 stars$36.14-3.1%$47.37+31.1%+127.1%$3.96B$398.99M-13.051,950Insider TradeNews CoverageOGNOrganon & Co.4.7363 of 5 stars$14.92+2.8%$20.80+39.4%-18.7%$3.85B$6.40B4.4810,000Positive NewsACLXArcellx2.026 of 5 stars$65.60-3.5%$108.46+65.3%+4.4%$3.60B$107.94M-92.3980Positive NewsGap DownRNAAvidity Biosciences2.5654 of 5 stars$29.52-6.6%$66.69+125.9%+10.8%$3.55B$10.90M-10.25190Insider TradeGap DownHigh Trading VolumeRAREUltragenyx Pharmaceutical4.3528 of 5 stars$36.21-4.3%$92.79+156.2%-24.1%$3.35B$560.23M-5.711,310News CoverageGap DownRYTMRhythm Pharmaceuticals4.2735 of 5 stars$52.97-3.3%$69.46+31.1%+29.7%$3.35B$130.13M-12.23140Gap DownSWTXSpringWorks Therapeutics1.9541 of 5 stars$44.13-6.9%$73.20+65.9%+0.5%$3.31B$191.59M-12.68230Positive NewsGap DownAKROAkero Therapeutics4.1348 of 5 stars$40.48-5.2%$76.29+88.5%+79.4%$3.22BN/A-10.7930Positive NewsGap DownCRNXCrinetics Pharmaceuticals4.3984 of 5 stars$33.54-3.4%$73.00+117.7%-31.8%$3.12B$1.04M-8.99210News CoveragePositive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies PTC Therapeutics Competitors Zai Lab Competitors Organon & Co. Competitors Arcellx Competitors Avidity Biosciences Competitors Ultragenyx Pharmaceutical Competitors Rhythm Pharmaceuticals Competitors SpringWorks Therapeutics Competitors Akero Therapeutics Competitors Crinetics Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADPT) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADPT Stock Free ADPT Stock Alerts